prevention.com
Cure8 news brief
Why This Matters
Delays in diagnosing IBD are common and can raise the risk of complications, so understanding when to push for testing matters. The article explains tests and differences between IBS and IBD to help people know when to seek further evaluation.
Who Should Pay Attention
Adults with chronic gut symptoms, newly diagnosed IBD patients, caregivers/parents, and primary-care clinicians.
Study Snapshot
Story typeMainstream News
Evidence typePatient Education
Source depthFull source text
What To Know
The story follows people who experienced long diagnostic journeys and quotes clinicians about why IBD is often missed or mistaken for IBS, hemorrhoids, or stress. It emphasizes being open with your clinician about bowel symptoms and that colonoscopy with biopsies plus targeted imaging are key to diagnosing IBD.
The piece also outlines differences between IBS (a brain–gut interaction disorder without visible inflammation) and IBD (inflammatory disease detectable on endoscopy/biopsy), mentions common symptom patterns and red flags, and notes that steroids may be used for short-term symptom control.
Keep In Mind
Patient-focused magazine article combining expert quotes and personal stories; it summarizes standard diagnostic approaches but is not a clinical guideline or original research.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationprevention.com
AuthorsMallory Creveling, CPT
Indexed viaBing News
Source typeWeb article
PublishedAug 25, 2026, 10:18 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
How to reduce the number of colonoscopies and improve follow-up for patients with Crohn's disease
Frequent routine colonoscopies after Crohn's surgery are invasive and burdensome. Using fecal calprotectin for regular monitoring could reduce unnecessary colonoscopies and detect recurrence earlier when inflammation is...
The Diagnostic Accuracy of Fecal Calprotectin for Colonoscopic Abnormalities in Patients With Chronic Diarrhea.
Fecal calprotectin measured by a point‑of‑care CGICA assay showed high accuracy for identifying colorectal inflammation and IBD in patients with chronic diarrhea, which could help avoid some unnecessary colonoscopies...
Feasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial
Self‑management programs delivered by nurses may help people with IBD improve daily functioning, confidence in managing their condition, and quality of life even when inflammation markers don’t change. That matters...